Know Cancer

or
forgot password

    • cancer clinical trials in lancaster, PA

    • Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Breast Cancer
    R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence
    Urological Associates of Lancaster, Ltd.
    Lancaster, Pennsylvania 17604
    Prostate Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy
    Urological Associates Of Lancaster
    Lancaster, Pennsylvania 17604-3200
    Metastatic Prostate Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
    Hem Onc Assoc Phys Lancaster
    Lancaster, Pennsylvania 17604
    Non-Small Cell Lung Cancer
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Breast Cancer, Cancer Survivor, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Sexuality and Reproductive Issues, Spiritual Concerns
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Efficacy Study of ABR-215050 to Treat Prostate Cancer
    Urological Associates Of Lancaster
    Lancaster, Pennsylvania 17604-3200
    Prostate Cancer
    Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Lung Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    S9925: Collecting and Storing Samples From Patients With Lung Cancer
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Lung Cancer
    A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma
    Location# 037
    Lancaster, Pennsylvania 17605
    Metastatic Colorectal Cancer
    Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal Translocation
    Lancaster Cancer Center
    Lancaster, Pennsylvania 17604
    Relapsed or Refractory Multiple Myeloma
    Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
    Lancaster Cancer Center
    Lancaster, Pennsylvania 17604
    Chronic Lymphocytic Leukemia
    Connect® MM- The Multiple Myeloma Disease Registry
    Lancaster Cancer Center
    Lancaster, Pennsylvania 17604
    Multiple Myeloma
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Breast Cancer
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Kidney Cancer
    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Breast Cancer
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Breast Cancer
    Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
    Lancaster General Health
    Lancaster, Pennsylvania 17601
    Chronic Myeloid Leukemia
    A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
    Urological Associates Of Lancaster
    Lancaster, Pennsylvania 17604-3200
    Prostatic Neoplasms
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Urological Associates Of Lancaster
    Lancaster, Pennsylvania 17604-3200
    Advanced Prostate Cancer, Prostatic Neoplasms
    DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma
    Urological Associates Of Lancaster
    Lancaster, Pennsylvania 17604-3200
    Urothelial Carcinoma
    A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
    Regional Gastroenterology Associates of Lancaster, Ltd.
    Lancaster, Pennsylvania 17604
    Crohn's Disease
    The Safety And Efficacy Of Maintenance Therapy With CP-690,550
    Regional Gastroenterology Associates of Lancaster, Ltd.
    Lancaster, Pennsylvania 17604
    Crohn's Disease
    Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer
    Urological Associates Of Lancaster
    Lancaster, Pennsylvania 17604-3200
    Bladder Cancer
    A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
    Regional Gastroenterology Associates of Lancaster, Ltd.
    Lancaster, Pennsylvania 17604
    Crohn's Disease
    Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
    Regional Gastroenterology Associates of Lancaster, Ltd.
    Lancaster, Pennsylvania 17604
    Ulcerative Colitis
    Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
    Urological Associates Of Lancaster
    Lancaster, Pennsylvania 17604-3200
    Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
    Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
    Oyster Point Family Health Center

    Trial Locations
    Oyster Point Family Health Center
    Heart Specialists of Lancaster County
    Obesity, Overweight
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Colorectal Cancer
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Melanoma (Skin)
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Breast Cancer
    A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN)
    Urology Associates of Lancaster
    Lancaster, Pennsylvania 17604
    Prostatic Intraepithelial Neoplasia
    A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer
    Urological Associates Of Lancaster
    Lancaster, Pennsylvania 17604-3200
    Prostate Cancer
    Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer
    Urological Associates Of Lancaster
    Lancaster, Pennsylvania 17604-3200
    Prostatic Neoplasms
    Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure
    Urological Assoc. of Lancaster
    Lancaster, Pennsylvania 17604-3200
    Prostatic Neoplasms
    A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes
    Lancaster Cancer Center LTD
    Lancaster, Pennsylvania 17605
    Myelodysplastic Syndromes
    Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer
    Lancaster General Hospital
    Lancaster, Pennsylvania 17604-3555
    Pancreatic Cancer
    Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma
    Lancaster Cancer Center, LTD
    Lancaster, Pennsylvania 17605
    Lymphoma, Follicular, Lymphoma, Mixed-Cell, Follicular, Lymphoma, Small Cleaved-Cell, Follicular, Lymphoma, Low-Grade
    Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer
    Urological Associates of Lancaster, Limited
    Lancaster, Pennsylvania 17604
    Kidney Cancer
    GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
    Urological Associates Of Lancaster

    Trial Locations
    Urological Associates Of Lancaster
    Lancaster Cancer Center, LTD
    Prostate Cancer